Diseases
Cognition Therapeutics, a clinical-stage company developing treatments for neurodegenerative disorders, has received final minutes from the U.S. Food and Drug Administration (FDA) concerning the end-of-Phase 2 meeting conducted on July 9, 2025. The FDA confirmed the proposed design of the Phase 3 program for zervimesine (CT1812), a treatment for
Associations
The Alzheimer's Association and its advocacy affiliate, Alzheimer's Impact Movement (AIM), have been advocating for increased research funding at the National Institutes of Health (NIH) to combat Alzheimer's and dementia. Their efforts have yielded significant results, with the Senate Appropriations Committee approving a $100
Associations
The Alzheimer's Association has presented the Jerome H. Stone Philanthropy Award for Alzheimer's Research to the Fred and Barbara Erb Family Foundation for their unwavering dedication to advancing Alzheimer's research. The Erb Family Foundation has been a partner of the Alzheimer's Association
Associations
The Alzheimer's Association has issued a landmark press release, releasing its first clinical practice guideline on the use of blood-based biomarker (BBM) tests for Alzheimer's disease diagnosis. The guideline, presented at the Alzheimer's Association International Conference, provides evidence-based recommendations for healthcare professionals to use
Associations
The VeraBIND Tau Assay, developed by Veravas Inc., has been shown to accurately measure pathologically active tau for early detection of Alzheimer's disease in both asymptomatic and symptomatic individuals. The assay, announced at the 2025 Alzheimer's Association International Conference (AAIC), has demonstrated high sensitivity and specificity
Diseases
Recent research has shed new light on the connection between aging and Alzheimer's disease (AD), revealing that hippocampal-cerebellar functional connectivity may be altered early in the course of AD. The study analyzed the role of genetic risk and cerebrospinal fluid biomarkers on the relationship between age and functional
Associations
HC-One's Mossdale Residence Care Home in York held a Dementia Support Coffee Morning event, providing a safe and friendly environment for people to share their experiences of dementia, connect with others, and learn more about the condition and available resources. The event featured a variety of activities, including
Associations
Optometrists Katherine Friis from Ripon Specsavers and her friend Nina, a lecturer at Teesside University, embarked on a challenging 26-mile trek along Yorkshire's coast to raise funds for Alzheimer's Society. The duo aimed to complete the scenic route within 12 hours, starting from Whitby and looping
Diseases
Circular Genomics, a global leader in circular RNA biomarkers for precision neurology and psychiatry, announced it has received a $250,000 investment from the Alzheimer's Drug Discovery Foundation (ADDF) through its Diagnostic Accelerator (DxA) program. The funding will support further studies of Circular Genomics' circRNA blood-based biomarkers
Diseases
A study has shed new light on the development of Alzheimer's disease (AD), with researchers at Virginia Commonwealth University identifying glutaminyl cyclase (QC) as a potential drug target. This discovery offers a promising therapeutic strategy against AD, which has become a pressing concern for the aging population. Current
Diseases
Research conducted by the University of Virginia has made a groundbreaking discovery in the field of Alzheimer's disease research. The study evaluated the association between exposure to nucleoside reverse transcriptase inhibitors (NRTIs), a class of anti-retroviral drugs, and the development of Alzheimer's disease in two large
Diseases
Coronavirus disease 2019 (COVID-19) has rapidly escalated into a global pandemic, primarily affecting older and immunocompromised individuals due to underlying clinical conditions and suppressed immune responses. New research has found that COVID-19 patients exhibit a spectrum of neurological symptoms, indicating that COVID-19 can affect the brain in various manners. The
